With advantages such as utilising bio-compatible materials, the biomolecule-based drug delivery system enables potentially safer drug development, according to the researchers.
Nanoparticle drug delivery
Researchers in Australia have created an innovative drug delivery system that utilises a metal–biomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. As the MBN nanoparticles do not require complicated drug ‘carriers’ and the materials are bio-compatible, the system has potential to boost successful drug development, according to first author Dr Wanjun Xu.